These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 6589752)

  • 1. A general survey of antibiotic treatment of staphylococcal septicaemia and endocarditis.
    Watanakunakorn C
    Scand J Infect Dis Suppl; 1983; 41():151-7. PubMed ID: 6589752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic treatment of staphylococcal septicaemia and endocarditis in a Swedish hospital.
    Svanbom M
    Scand J Infect Dis Suppl; 1983; 41():161-72. PubMed ID: 6589754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of beta-lactam antibiotics in the treatment of septicaemia and endocarditis.
    Watanakunakorn C
    Scand J Infect Dis Suppl; 1984; 42():110-6. PubMed ID: 6442009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
    Lowy FD; Wexler MA; Steigbigel NH
    J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcus aureus bacteremia and endocarditis.
    Chang FY
    J Microbiol Immunol Infect; 2000 Jun; 33(2):63-8. PubMed ID: 10917874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of staphylococcal septicaemia in compromised hosts.
    Solberg CO; Digranes A; Kalager T
    Scand J Infect Dis Suppl; 1983; 41():177-86. PubMed ID: 6589756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vancomycin in the treatment paradigm.
    Stevens DL
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA; Courtney KB
    J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
    Chang FY; Peacock JE; Musher DM; Triplett P; MacDonald BB; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
    Medicine (Baltimore); 2003 Sep; 82(5):333-9. PubMed ID: 14530782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
    Siaperas P; Pefanis A; Iliopoulos D; Katsarolis I; Kyroudi-Voulgari A; Donta I; Karayiannakos P; Giamarellou H
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New agents for Staphylococcus aureus endocarditis.
    Drees M; Boucher H
    Curr Opin Infect Dis; 2006 Dec; 19(6):544-50. PubMed ID: 17075329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus.
    Rayner C; Munckhof WJ
    Intern Med J; 2005 Dec; 35 Suppl 2():S3-16. PubMed ID: 16271060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy and prevention of infectious endocarditis].
    Horstkotte D; Rosin H
    Schweiz Med Wochenschr; 1984 Nov; 114(45):1575-86. PubMed ID: 6515354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy.
    Murray HW; Wigley FM; Mann JJ; Arthur RR
    Arch Intern Med; 1976 Apr; 136(4):480-3. PubMed ID: 1267557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Madrigal AG; Basuino L; Chambers HF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aminoglycosides in the treatment of infectious endocarditis].
    Malinverni R
    Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.